Life Science CEO Reflects on Modern Fundraising
Venture-backed companies in the genomic sequencing and analysis space have seen a few big financings and acquisitions in recent months. But for the most part, life science fundraising s as challenging as ever, says Roopom Banerjee, whose company, RainDance Technologies, just closed a $20 million late-stage round.
29 April 2013•3 mins read
